Amar Akhtar Sethi - 25 Nov 2025 Form 4 Insider Report for VivoSim Labs, INC. (VIVS)

Role
Chief Scientific Officer
Signature
/s/ Norman Staskey, attorney-in-fact
Issuer symbol
VIVS
Transactions as of
25 Nov 2025
Net transactions value
$0
Form type
4
Filing time
26 Nov 2025, 18:09:37 UTC
Previous filing
26 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sethi Amar Akhtar Chief Scientific Officer 11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO /s/ Norman Staskey, attorney-in-fact 26 Nov 2025 0002098023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIVS Options (right to buy) Award $0 +53,500 $0.000000 53,500 25 Nov 2025 Common Stock 53,500 $2.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a four year period, with 25% of the total number of shares subject to the option vesting on November 24, 2026, and the balance vesting in 12 equal quarterly installments thereafter.